MedPath

Brian Callaghan

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects

Completed
Conditions
Neuropathy
Metabolic Syndrome
Obesity
First Posted Date
2016-02-24
Last Posted Date
2020-02-05
Lead Sponsor
Brian Callaghan
Target Recruit Count
177
Registration Number
NCT02689661
Locations
🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.